Business

February 4, 2014 12:46 PM

Furiex shares jump 130% on positive drug trial results

Shares of Furiex Pharmaceuticals surged 130 percent after the Morrisville drug development company reported positive test results for its irritble bowel syndrome treatment.

Related content

Comments